Feature Channels: Vaccines

Filters close
Released: 18-Oct-2022 4:05 PM EDT
Comparative safety of Pfizer-BioNTech COVID-19 vaccine vs non–SARS-CoV-2 vaccines in children younger than age 5
JAMA - Journal of the American Medical Association

The symptoms reported after administration of the Pfizer-BioNTech COVID-19 vaccine were comparable overall to those for approved non–SARS-CoV-2 vaccines in this study including 7,800 children younger than age 5.

Newswise: Penn State scientists one step closer to adaptation-proof COVID-19 vaccine
Released: 18-Oct-2022 10:05 AM EDT
Penn State scientists one step closer to adaptation-proof COVID-19 vaccine
Penn State College of Medicine

A vaccine that could protect against new variants of SARS-CoV-2 and also potentially protect against other coronaviruses is one step closer to reality thanks to College of Medicine researchers.

Newswise: Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Released: 18-Oct-2022 8:30 AM EDT
Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Florida Atlantic University

FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.

Released: 17-Oct-2022 3:45 PM EDT
Five Penn Medicine Experts Elected to National Academy of Medicine
Perelman School of Medicine at the University of Pennsylvania

Five experts from the Perelman School of Medicine at the University of Pennsylvania have been elected to the National Academy of Medicine (NAM), one of the nation’s highest honors in the fields of health and medicine. Regina Cunningham, Elizabeth Howell, Steven Joffe, Katalin Karikó, and Drew Weissman are among the 100 new members, elected by current NAM members.

Newswise: Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study
Released: 17-Oct-2022 8:30 AM EDT
Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study
National Comprehensive Cancer Network® (NCCN®)

New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment.

Released: 13-Oct-2022 2:05 PM EDT
Risk of Severe Breakthrough COVID-19 Infection Is Higher for People With HIV With Moderately Low CD4 Cell Counts
Johns Hopkins Bloomberg School of Public Health

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 “breakthrough” infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Newswise: Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Released: 13-Oct-2022 8:00 AM EDT
Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Johns Hopkins Medicine

It’s that time of year: costumes, candy and trick-or-treating. As families celebrate this season, Johns Hopkins Children’s Center experts are available for interviews on a variety of tips to help ensure a safe and fun Halloween.

Released: 12-Oct-2022 3:50 PM EDT
Rutgers Seeks Participants for Monkeypox Treatment Study
Rutgers University-New Brunswick

Rutgers New Jersey Medical School is one of nearly 80 sites in the United States that will enroll participants in a new study to evaluate whether tecovirimat is effective in treating human monkeypox.

Released: 11-Oct-2022 6:30 PM EDT
The NIH/DAIDS Cross-Network (ACTG/HVTN/IMPAACT) TB Vaccine Working Group calls for people living with HIV to be included in tuberculosis vaccine development
HIV Vaccine Trials Network

People living with HIV must be included in clinical trials for new tuberculosis vaccine candidates currently in the development pipeline, say experts on an international panel convened last year to address gaps in the current TB vaccine landscape. Their recommendations appear in a new paper published today in The Lancet HIV.

Newswise: It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Released: 11-Oct-2022 2:05 PM EDT
It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Rutgers Cancer Institute

Flu season is here. Rutgers Cancer Institute expert shares what cancer patients and their families need to know.

Released: 11-Oct-2022 7:05 AM EDT
Pandemic prep needs ‘smart surveillance’ to predict viral spillovers
Ohio State University

“Smart surveillance” for viral spillover from animals to humans, targeted preparedness & drug/vaccine research, & worldwide cooperation on stopping disease spread are required to reduce deaths & lessen economic consequences of the next pandemic, according to an international team of scientists.

   
Released: 10-Oct-2022 7:05 AM EDT
Other SARS-CoV-2 Proteins are Important for Disease Severity, Aside from the Spike
University of Maryland School of Medicine

University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The genes control the immune system of the host, contributing to how fiercely the body responds to a COVID-19 infection.

Newswise: Vaginal immune system may hint at prime vaccine timing
Released: 7-Oct-2022 1:05 PM EDT
Vaginal immune system may hint at prime vaccine timing
University of Washington School of Medicine

A meta-analysis of 32 studies showed that the immune system within the vagina ebbs and flows, depending on menstrual-cycle stage. The analysis identified 53 distinct messages that immune cells sent to one another.

Released: 6-Oct-2022 2:55 PM EDT
Referrals to long COVID clinic fall by 79% following roll-out of the vaccine
University of Cambridge

Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine.

Released: 6-Oct-2022 11:50 AM EDT
COVID-19: Boosting with an mRNA vaccine offers better protection in people who received two doses of CoronaVac
N/A

One year after mass vaccination against COVID-19 was launched, inactivated virus vaccines accounted for half of the doses administered worldwide.

Released: 6-Oct-2022 9:55 AM EDT
Scientists shed light on COVID-19 booster dose effectiveness among the elderly in Japan
Okayama University

The coronavirus 2019 disease (COVID-19) pandemic has affected millions worldwide and claimed multiple lives. The elderly—aged above 60 years—remain the most vulnerable group.

Released: 5-Oct-2022 2:35 PM EDT
No quick fix for COVID-19 vaccine hesitancy among UK South Asian communities
SAGE Publications UK

The complex, multiple factors influencing COVID-19 vaccine hesitancy and scepticism among UK South Asian communities mean ‘quick fix’ solutions to increase uptake of the vaccines will be ineffective, according to new research published by JRSM Open.

   
Newswise: UCLA Fielding School of Public Health-led research demonstrates the importance of influenza vaccination globally
Released: 5-Oct-2022 12:05 PM EDT
UCLA Fielding School of Public Health-led research demonstrates the importance of influenza vaccination globally
UCLA Fielding School of Public Health

An international team of researchers has demonstrated that among patients hospitalized for influenza, those who were vaccinated had less severe infections, including reducing the odds for children requiring admittance to an intensive care unit by almost half.



close
2.41964